Conclusion
In symptomatic AF patients, the effectiveness of an active rhythm control strategy has been emphasized. However, rhythm control strategy in patients with AF who have SVR should be undertaken with caution. Careful patient selection based on the pathogenesis of AF and risk-benefit assessment may be crucial. Further prospective and large-scale randomized studies on rhythm control strategies for patients with AF and SVR are required.